Fabrication and Reduction of pH Dual Bio-Responsive Poly(ether-urethane) Nanocarriers for Targeted Drug Delivery

被引:8
|
作者
Li, Liubing [1 ]
Lu, Yufeng [1 ]
Zhang, Moyu [2 ,3 ]
Zhao, Yuhao [2 ,3 ]
Li, Xueqing [2 ,3 ]
Dong, Qirong [1 ]
Shen, Liqin [1 ]
Wang, Yangyun [2 ,3 ]
机构
[1] Soochow Univ, Affiliated Hosp 2, Suzhou 215004, Peoples R China
[2] Soochow Univ, Collaborat Innovat Ctr Radiat Med, Jiangsu Higher Educ Inst, Sch Radiol & Interdisciplinary Sci RAD X, Suzhou 215123, Peoples R China
[3] Soochow Univ, Sch Radiat Med & Protect, Suzhou 215123, Peoples R China
基金
中国国家自然科学基金;
关键词
Poly(ether-urethane); Dual-Responsive Nanocarriers; Targeted and Efficient Drug Delivery; ELECTROCATALYTIC ACTIVITY; COMPOSITE ELECTRODE; BLOCK-COPOLYMERS; ANTICANCER DRUG; GRAPHENE OXIDE; NANOPARTICLES; REDOX; DOXORUBICIN; CONJUGATE; MICELLES;
D O I
10.1166/nnl.2018.2588
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
This current study employed pH-and GSH-sensitive copolymers to prepare nanocarriers for targeted and efficient drug delivery. The nanocarriers were constructed by a family of dual pH-and GSH-responsive copolymers synthesized from poly(ethylene glycol) (PEG), 2,2'-dithiodiethanol (DiT), N-methyldiethanolamine (MDEA) and hexamethylene diisocyanate (HDI). As a commonly used targeting ligand, hyaluronic acid (HA) chains were found to be semi-interpenetrated into the surface of the nanocarriers. Results from these studies demonstrated that the DOX-loaded dual stimuli-responsive nanocarriers with HA modification exhibited excellent tumor targeting, successful cell intake, and anti-cancer activity with minimal systemic toxicity. The DOX-loaded dual stimuli-responsive nanocarriers have special potential for targeted therapy against CD44-expressing tumor.
引用
收藏
页码:13 / 22
页数:10
相关论文
共 50 条
  • [1] Multi-segmented poly(ether-urethane)s as potential dual-stimuli-responsive drug delivery carriers
    Wang, Yangyun
    Wu, Guolin
    Li, Xiaomeng
    Wang, Yinong
    Ma, Jianbo
    JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) : E83 - E83
  • [2] A concise review on bio-responsive polymers in targeted drug delivery system
    Dipanjan Karati
    Polymer Bulletin, 2023, 80 : 7023 - 7045
  • [3] A concise review on bio-responsive polymers in targeted drug delivery system
    Karati, Dipanjan
    POLYMER BULLETIN, 2023, 80 (07) : 7023 - 7045
  • [4] Sodium alginate coated mesoporous silica for dual bio-responsive controlled drug delivery
    Yuan, Ning-ning
    Li, Shan-ji
    Li, Guo-qiang
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 46 : 348 - 353
  • [5] Mesoporous silica-chondroitin sulphate hybrid nanoparticles for targeted and bio-responsive drug delivery
    Radhakrishnan, Krishna
    Tripathy, Jasaswini
    Datey, Akshay
    Chakravortty, Dipshikha
    Raichur, Ashok M.
    NEW JOURNAL OF CHEMISTRY, 2015, 39 (03) : 1754 - 1760
  • [6] Folate-Modified pH and ROS Dual-Responsive Polymeric Nanocarriers for Targeted Anticancer Drug Delivery
    Dai, Fanjia
    Chen, Fengjiao
    Zhang, Jiaying
    Chen, Xianwu
    Liang, Hongze
    Liang, Zhenjiang
    Zhang, Shun
    Tan, Hui
    Zhao, Lingling
    ACS APPLIED NANO MATERIALS, 2024, 7 (07) : 7289 - 7299
  • [7] pH and redox dual responsive nanoparticle for targeted drug delivery
    Bahadur, Remant K. C.
    Xu, Peisheng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [8] Ultrasensitive GSH-Responsive Ditelluride-Containing Poly(ether-urethane) Nanoparticles for Controlled Drug Release
    Wang, Yangyun
    Zhu, Lina
    Wang, Yong
    Li, Liubing
    Lu, Yufeng
    Shen, Liqin
    Zhang, Leshuai W.
    ACS APPLIED MATERIALS & INTERFACES, 2016, 8 (51) : 35106 - 35113
  • [9] Biomineralization inspired surface engineering of nanocarriers for pH-responsive, targeted drug delivery
    Chen, Zhaowei
    Li, Zhenhua
    Lin, Youhui
    Yin, Meili
    Ren, Jinsong
    Qu, Xiaogang
    BIOMATERIALS, 2013, 34 (04) : 1364 - 1371
  • [10] pH and Redox Dual Responsive Nanoparticle for Nuclear Targeted Drug Delivery
    Bahadur, Remant K. C.
    Thapa, Bindu
    Xu, Peisheng
    MOLECULAR PHARMACEUTICS, 2012, 9 (09) : 2719 - 2729